Juel, V. C., Sanders, D. B., Hobson-Webb, L. D., Massey, J. M., Guptill, J. T., O’Brien, F., … Howard, J. F. (2017). Marked clinical and jitter improvement after eculizumab in refractory myasthenia. Muscle Nerve, 56(3), E16–E18. https://doi.org/10.1002/mus.25620

Juel, Vern C., Donald B. Sanders, Lisa D. Hobson-Webb, Janice M. Massey, Jeffrey T. Guptill, Fanny O’Brien, Jing Jing Wang, and James F. Howard. “Marked clinical and jitter improvement after eculizumab in refractory myasthenia.” Muscle Nerve 56, no. 3 (September 2017): E16–18. https://doi.org/10.1002/mus.25620.

Juel VC, Sanders DB, Hobson-Webb LD, Massey JM, Guptill JT, O’Brien F, et al. Marked clinical and jitter improvement after eculizumab in refractory myasthenia. Muscle Nerve. 2017 Sep;56(3):E16–8.

Juel, Vern C., et al. “Marked clinical and jitter improvement after eculizumab in refractory myasthenia.” Muscle Nerve, vol. 56, no. 3, Sept. 2017, pp. E16–18. Pubmed, doi:10.1002/mus.25620.

Juel VC, Sanders DB, Hobson-Webb LD, Massey JM, Guptill JT, O’Brien F, Wang JJ, Howard JF. Marked clinical and jitter improvement after eculizumab in refractory myasthenia. Muscle Nerve. 2017 Sep;56(3):E16–E18.